GSTP1 and cancer: Therefore, pro-oxidant cancer drugs dramatically increase intracellular ROS and thus, induce oxidative stress by interfering with ROS homeostatic regulators such as glutathione S-transferase pi 1 (GSTP1) (Choi et al., 2019).